Northern Lincolnshire’s Director of Public Health is urging people to be cautious as infection rates spike in North Lincolnshire.
Steve Pintus, said:
“We have seen infection rates in the area more than double in the last week with people aged under 25 seeing a dramatic rise. As restrictions are eased there is a real risk that our area will see even higher figures in the coming weeks. If you haven’t had a vaccination then please come forward quickly and also encourage any of your friends and family to get the jab.
“While the vaccine offers good levels of protection, and has broken the link between infections and hospitalisation, people still need to be cautious to protect themselves and each other.
“The pace of the vaccine rollout in North Lincolnshire has been impressive, but a worrying 20,000 people aged over 18 have still not had their first jab. I would urge everyone who hasn’t yet come forward to either book a slot, or just pop-in to the Baths Hall. It is vital we get as many people as possible vaccinated before restrictions are eased on 19 July.
“Second vaccinations offer a much higher level of protection so again we need people to make sure they get their second dose. This also means people will not have to self-isolate if they have been close to someone with the virus from 16 August and travel is likely to be much easier.
“The Government are planning to remove restrictions from 19 July but the advice on keeping safe remains. It is down to each of us to assess risks, make the right choices and take self-responsibility. The advice is:
“Meet in well-ventilated areas where possible, such as outdoors or indoors with windows open.
Wear a face covering where you come into contact with people you don’t normally meet in enclosed and crowded spaces.
Wash your hands with soap and water or using hand sanitiser regularly throughout the day.
Cover your nose and mouth when you cough and sneeze.
Stay at home if unwell, to reduce the risk of passing on other illnesses onto friends, family, colleagues, and others in your community.
Consider individual risks, such as clinical vulnerabilities and vaccination status.”